Showing results (171-180 of 233) with videos related to
Sort By:
Pageof 24
Polish Journal of Pharmacology and Pharmacy|March 1, 1992
Synthesis and some pharmacological properties of new V1/V2 antagonists of arginine-vasopressin with structural changes at their N-terminalsB Lammek, E Konieczna, T Wierzba, et al.The New England Journal of Medicine|October 25, 1984
Renal revascularization in the azotemic hypertensive patient resistant to therapyC Y Ying, C P Tifft, H Gavras, et al.The Western Journal of Medicine|March 1, 1993
Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?M P Sambhi, H Gavras, J I Robertson, et al.Biochimica Et Biophysica Acta|March 4, 2000
A role for the A3 adenosine receptor in determining tissue levels of cAMP and blood pressure: studies in knock-out miceZ Zhao, K Makaritsis, C E Francis, et al.Hypertension (Dallas, Tex. : 1979)|June 1, 1990
Expression of multiple alpha 2-adrenergic receptor messenger RNA species in rat tissuesC S Flordellis, M Castellano, R Franco, et al.Hypertension (Dallas, Tex. : 1979)|December 18, 1998
Alpha1-adrenergic plus angiotensin receptor blockade reduces atherosclerosis in apolipoprotein E-deficient miceK P Makaritsis, H Gavras, Y Du, et al.Schweizerische Medizinische Wochenschrift|December 9, 1978
[Chronic treatment of hypertension by an inhibitor of angiotensin converting enzyme]B Waeber, H Gavras, H R Brunner, et al.Lancet (London, England)|June 9, 1979
Improvement of chronic congestive heart-failure by oral captoprilG A Turini, H R Brunner, M Gribic, et al.Journal of Human Stress|September 1, 1978
Studies on the activity of the sympathetic nervous system in essential hypertensionA V Chobanian, H Garvras, I Gavras, et al.Hypertension (Dallas, Tex. : 1979)|March 1, 1996
Localization of alpha 2A- and alpha 2B-adrenergic receptor subtypes in brainA Tavares, D E Handy, N N Bogdanova, et al.Pageof 24